XML 25 R15.htm IDEA: XBRL DOCUMENT
v3.23.3

Earnings Per Share | 3 Months Ended
--- | ---
Sep. 30, 2023
Notes to Financial Statements |
Earnings Per Share | Note 9. Earnings Per Share: The following table reflects the calculation of basic and diluted earnings per share (in thousands, except per share amounts):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ | Quarter Ended
​ | ​ | ​ | September 30,
​ |  | ​ | 2023 |  | 2022
Earnings per share – basic: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net earnings, including noncontrolling interest | ​ | ​ | $ | 50,993 |  | $ | 89,734
Less net earnings (loss) attributable to noncontrolling interest | ​ | ​ | ​ | — |  | ​ | 179
Net earnings attributable to Bio-Techne | ​ | ​ | $ | 50,993 | ​ | $ | 89,555
Income allocated to participating securities | ​ | ​ |  | (8) | ​ |  | (26)
Income available to common shareholders | ​ | ​ | $ | 50,985 | ​ | $ | 89,529
Weighted-average shares outstanding – basic | ​ | ​ |  | 158,130 | ​ |  | 156,929
Earnings per share – basic | ​ | ​ | $ | 0.32 | ​ | $ | 0.57
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Earnings per share – diluted: | ​ | ​ |  |  | ​ |  |
Net earnings, including noncontrolling interest | ​ | ​ | $ | 50,993 | ​ | $ | 89,734
Less net earnings (loss) attributable to noncontrolling interest | ​ | ​ | ​ | — | ​ | ​ | 179
Net earnings attributable to Bio-Techne | ​ | ​ | $ | 50,993 | ​ | $ | 89,555
Income allocated to participating securities | ​ | ​ |  | (8) | ​ |  | (26)
Income available to common shareholders | ​ | ​ | $ | 50,985 | ​ | $ | 89,529
Weighted-average shares outstanding – basic | ​ | ​ |  | 158,130 | ​ |  | 156,929
Dilutive effect of stock options and restricted stock units | ​ | ​ |  | 3,810 | ​ |  | 5,243
Weighted-average common shares outstanding – diluted | ​ | ​ |  | 161,940 | ​ |  | 162,172
Earnings per share – diluted | ​ | ​ | $ | 0.31 | ​ | $ | 0.55
​ The dilutive effect of stock options and restricted stock units in the above table excludes all options for which the aggregate exercise proceeds exceeded the average market price for the period. The number of potentially dilutive option shares excluded from the calculation was 4.1 million and 4.5 million for the quarter ended September 30, 2023 and 2022, respectively.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration